Your shopping cart is currently empty

(+)-JJ-74-138 is a novel non-competitive androgen receptor (AR) antagonist capable of inhibiting enzalutamide-resistant castration-resistant prostate cancer (CRPC).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,520 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $3,080 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,800 | 10-14 weeks | 10-14 weeks |
| Description | (+)-JJ-74-138 is a novel non-competitive androgen receptor (AR) antagonist capable of inhibiting enzalutamide-resistant castration-resistant prostate cancer (CRPC). |
| In vitro | (+)-JJ-74-138, a potent analog of JJ-450, effectively inhibits androgen-independent activation of the androgen receptor (AR) in cell lines expressing splice variants of AR lacking the LBD. It suppresses mRNA expression of AR and ARv7 target genes and reduces nuclear AR levels in the absence of androgens. |
| Molecular Weight | 514.48 |
| Formula | C22H22F8N2OS |
| Cas No. | 2135545-34-3 |
| Smiles | C(=O)([C@H]1[C@H](C1)C2=CC(S(F)(F)(F)(F)F)=CC=C2)N3CCN(CC3)C4=CC(C(F)(F)F)=CC=C4C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.